Social media posts on orphan designated drugs increased in the pharma industry in Q1 2023
Notably, Covid-19 was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions ahead of orphan designated drugs and innovation, according to GlobalData.
Of the 50 leading companies in the pharma industry, Teva Pharmaceutical Industries had the most mentions of orphan designated drugs in Q1 2023. GlobalData identified 35,996 orphan designated drugs-related posts in the industry’s social media activity – 2% of all posts – and an increase of 9% in Q1 2023 compared with Q4 2022.
For further understanding of GlobalData’s New Drug Approvals and Their Contract Manufacture – 2023 Edition buy the report here.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Social Media Analytics uses machine learning to uncover key insights and track sentiment across millions of social media posts across selected Twitter influencers and Reddit channels.
Source link
#Social #media #posts #orphan #designated #drugs #increased #pharma #industry
